The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

We've assessed creatine supplements from brands including Bulk, Free Soul, Holland & Barrett, MyProtein and more to uncover ...

Looking to find your next favourite podcast? Radio X has some top choices from the past year: comedy, true crime, news and ...

Experts explain the science behind this supplement and why so many women are turning to creatine for a number of potetential ...

Brendan Gallagher isn't having an easy season. The veteran has just one goal in 24 games, and it doesn't exactly feel like it's about to unblock. And of course, it's not because he's taking it easy: ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Eliquis (apixaban) is a prescription oral tablet used to reduce the risk of stroke in certain adults and to treat or prevent blood clots in certain adults and children. The Eliquis dosage you’re ...

Sept 23 (Reuters) - The U.S. Food and Drug Administration has declined to approve a higher-dose version of Biogen's (BIIB.O), opens new tab drug for a rare genetic disorder that causes progressive ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

“These results will help physicians simplify the treatment of syphilis for patients and reduce the time and inconvenience associated with multiple injections of penicillin administered in the past,” ...

Creatine is one of the most widely used dietary supplements for improving exercise performance. It provides the muscles with energy for short-term, high-intensity workouts like weight lifting. It may ...

New data from Biogen shows improved motor function in SMA patients using a higher dose of nusinersen, highlighting early treatment benefits. Biogen announced new data from the DEVOTE Part C and ...